.
Since 2020, South Africa has become the world’s champion in the call for equitable access to Covid-19 vaccines. On multilateral platforms, the government has been clear in its call for equitable and universal access to Covid-19 medical products and treatments not only for South Africa, but for the rest of the continent too.
The government has, at least in its rhetoric at high-level political gatherings, spoken out against vaccine nationalism and challenged the historically dominant power dynamics of pharmaceutical manufacturers. To support these statements, the government has, with India, jointly proposed a patent waiver on Covid-19 health technologies at the World Trade Organisation’s (WTO) Trade-Related Aspects of Intellectual Property Rights (Trips) Council.
BMW Sicherheits-Roller mit crashsicherem Rahmen
motorradonline.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from motorradonline.de Daily Mail and Mail on Sunday newspapers.
Patent Infringement
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Three Barriers That Stand in the Way of Global Vaccination
Evolutionary pressure on the virus will inevitably favour mutations that make the disease more transmissible, or the virus itself more vaccine-resistant. It is clear, therefore, that every nation’s interest is in universal vaccination. But this is not the trajectory we are on.
We will not be able to put the COVID-19 pandemic behind us until the world’s population is mostly immune through vaccination or previous exposure to the disease.
A truly global vaccination campaign, however, would look very different from what we are seeing now. For example, as of January 20, many more people have been immunised in Israel (with a population less than 10 million) than in Africa and Latin America combined.